Skip to main content

MHRA Approves Nuromol (Combined Paracetamol and Ibuprofen) for General Sale in UK

By August 20, 2021No Comments

On 16 August, 2021, the UK Medicine and Healthcare products Regulatory Agency (MHRA) made Nuromol, a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet, available without the need to visit a pharmacy, providing an important new treatment option for temporary relief of mild to moderate pain.  PEGUS was privileged to support label development and self-selection testing, and warmly congratulates the sponsor on this new GSL nonprescription product approval success.

This is the second fixed-dose combination pain reliever approval supported by PEGUS, and our third UK nonprescription approval success.